OncoMed to Present Data on Multiple Anti-Cancer Stem Cell Candidates at the … – Nasdaq
|
OncoMed to Present Data on Multiple Anti-Cancer Stem Cell Candidates at the …
Nasdaq REDWOOD CITY, Calif., March 19, 2015 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals Inc. (Nasdaq:OMED) will present new data related to its clinical and preclinical anti-cancer stem cell and immuno-oncology candidates in a total of seven … |
